New lipid nanoparticles deliver mRNA 100x better to cells and AI helps design better vaccines

Key Findings

🤖 AI screening identifies mRNA particles that target bone marrow 3x better

• Researchers used NIR-II imaging to screen 122 different lipid nanoparticle formulations simultaneously, identifying lead candidates with superior bone marrow targeting

• The top performer (BONE-2) achieved 3.3-fold improvement in bone marrow mRNA transfection compared to commercial formulations

• Flow cytometry revealed the particles preferentially targeted myeloid immune cells including monocytes, macrophages, and dendritic cells

💊 Microneedle patches deliver stable mRNA vaccines for weeks without refrigeration

• Scientists developed microneedle patches that kept mRNA-lipid nanoparticle vaccines stable for 1 month at 4°C and 2 weeks at room temperature (25°C)

• The patches induced both lung and systemic immune responses, providing some protection against SARS-CoV-2 pseudovirus lung invasion in mice

• The system targets skin immune cells directly, potentially eliminating the need for trained medical staff and cold storage chains

🧬 New mRNA design bypasses cellular blockades and reduces immune reactions

• Engineers created VPg saRNA vectors that work independently of cellular cap-dependent translation machinery, enabling function even when normal protein production is restricted

• The system achieved precise encoding of therapeutic proteins while maintaining low immunogenicity compared to conventional self-amplifying RNA

• Applications included treating tumor-associated weight loss, encoding cancer-fighting proteins, and therapy for autoimmune graft-versus-host disease

🏥 Hepatitis B mRNA vaccines clear virus better than protein vaccines in mice

• mRNA vaccines encoding hepatitis B surface antigens achieved virus clearance and DNA reduction in chronic infection mouse models, outperforming protein-based comparators

• Two phase I clinical trials have begun testing therapeutic mRNA approaches, including ARCUS gene editing delivered via lipid nanoparticles

• The platform offers rapid development cycles and intrinsic immune-stimulating properties compared to traditional protein vaccines

🧪 Comprehensive database maps 19,528 lipid nanoparticles for better design

• Scientists created the Lipid Nanoparticle Database (LNPDB) consolidating structural and functional data for 19,528 different formulations

• The database generates molecular simulation files and identified key structural features—bilayer stability and packing parameters—that correlate with delivery performance

• Machine learning models trained on this data can now predict which lipid combinations will work best for specific applications

🔬 Skin gene editing corrects genetic disease mutations with 30% efficiency

• Researchers achieved ~30% restoration of normal enzyme activity by correcting the most common mutation causing severe genetic skin disease (autosomal recessive congenital ichthyosis)

• Lipid nanoparticles delivered cytosine base editors topically after barrier modulation, with no systemic distribution detected

• Comprehensive safety testing showed excellent profiles even after repeated applications, with no off-target genetic changes